Figure 1—figure supplement 3. | Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Open accessCopyright infoDownload PDFDownload figures

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Figure 1—figure supplement 3.

Affiliation details

University of Washington, United States; Fred Hutchinson Cancer Research Center, United States; University of Missouri, United States
Figure 1—figure supplement 3.
Download figureOpen in new tabFigure 1—figure supplement 3. Survival plots of male mice treated with 8 mg/kg/day i.p. rapamycin for 90 days starting around 600 days of age.

Gray box approximately indicates treatment period. Note: although the curves start at age=0 to represent all of life, we have no data on animals that may have died in this cohort prior to receipt from NIA (dashed lines). N=18 vehicle injected, N=17 rapamycin.

DOI: http://dx.doi.org/10.7554/eLife.16351.006